Table 2.
Patient statistics by PPG categories.
| Moderate | Severe | |||
|---|---|---|---|---|
| DP | RP | DP | RP | |
| No. of samples | 94 | 182 | 53 | 75 |
| No. of patients | 52 | 72 | 28 | 27 |
| Male/female | 26/26 | 39/33 | 17/11 | 16/11 |
| Age | 55.02 ± 15.69 | 54.75 ± 15.04 | 63.57 ± 11.29 | 60.7 ± 15.52 |
| WHO scale | 4.24 ± 0.43 | 4.29 ± 0.45 | 6.39 ± 1.34 | 6.29 ± 1.34 |
| Neutrophil | 67.49 ± 13.57 | 67.68 ± 12.72 | 84.99 ± 8.98 | 83.91 ± 9.05 |
| Lymphocyte | 22.79 ± 11.3 | 22.93 ± 10.58 | 8.21 ± 6.6 | 9.08 ± 6.66 |
| LDH, U/L | 447.26 ± 221.44 | 710.85 ± 974.88 | 1519.1 ± 1384.94 | 1761.23 ± 1311.73 |
| D-dimers | 650.92 ± 899.32 | 467.21 ± 241.41 | 961.66 ± 566.06 | 888.49 ± 509.09 |
| Days of hospitalization | 15.9 ± 5.38 | 15.8 ± 6.08 | 20.4 ± 8.67 | 20.5 ± 9.12 |
The distribution and clinical characteristics of patients in the DP and RP are shown per severeness. The WHO scale, neutrophil count, and LDH levels were similar within the same severity category, even when comparing different PPGs. However, they exhibited different levels across the severity groups, with higher values observed in the severe patients.